⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ETON News
Eton Pharmaceutcials, Inc. Common Stock
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
ETON
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
globenewswire.com
ETON
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
globenewswire.com
ETON
Form 8-K
sec.gov
ETON
Form 8-K
sec.gov
ETON
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
globenewswire.com
ETON
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
globenewswire.com
ETON
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
globenewswire.com
ETON
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
globenewswire.com
ETON
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
globenewswire.com
ETON